[1] Chung JK,Kim YK,Kim SK,et al.Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo-or isonietabolic on 18F-FDG PET.Eur J Nucl Med Mol Imaging,2002,29(2):176-182.
[2] Langen KJ,Muhlensiepen H,Holschbach M,et al.Transport mechanisms of 3-[123]iodo-α-methvl-L-tyrosine in a human glioma cell line:comparison with [3H-methy]]-L-methionine.J Nucl Med,2000,41(7):1250-1255.
[3] Kracht LW,Friese M,Herholz K.et al.Methyl-[11C]-L-rnethionine uptake as measured by positron emission tomography correlates to microvessel density in patienls with glioma.Eur J Nucl Med Mol Imaging,2003,30(6):868-873.
[4] Giammarile F,Cinotti LE,Jouvet A,et al.High and low grade oligodendrogliomas (ODG):correlation of amino-acid and glucose uptakes using PET and histological classifications.J Neurooncol,2004,68(3):263-274.
[5] Sunada I,Tsuyuguchi N,Hara M,et al.18F-FDG and 11C-methionine PET in choroid plexus papilloma-report of three cases.Radiat Med,2002,20(2):97-100.
[6] Rau FC,Weber WA,Wester HJ,et al.O-(2-[18F]Fluoroethyl)-L-tyrosine (FET):a tracer for differentiation of tumour from inflammation in murine lymph nodes.Eur J Nucl Med Mol Imaging,2002,29(8):1039-1046.
[7] Kaim AH,Weber B,Kurrer MO,et al.18F-FDC and 18F-FET uptake in experimental soft tissue infection.Eur J Nucl Med Mol Imaging,2002,29(5):648-654.
[8] Weber WA,Wester HJ,Grosu AL,et a l.O-(2-[18FJFluoroethyl)-L-tyrosine and L-[methyl-11C] methionine uptake in brain tumours:initial results of a comparative study.Eur J Nucl Med Mol Imaging,2000,27(5):542-549.
[9] Floeth FW,Pauleit D,Wittsack HJ,et al.Multimodal metabolic imaging of cerebral gliomas:positron emission tomography with [18F] fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.J Neurosurg,2005,102(2):318-327.
[10] Pauleit D,Stoffels G,Schaden W,et al.PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors:first clinical results.J Nucl Med,2005,46(3):411-416.
[11] Ohtani T,Kurihara H,Ishiachi S,et al.Brain tumour imaging with carbon-11 choline:comparison with FDG PET and gadolinium-enhanced MR imaging.EurJ Nucl Med Mol Imaging,2001,28(11):1664-1670.
[12] Kwee SA,Coel MN,Lim J,et al.Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation.J Neuroimaging,2004,14(3):285-289.
[13] Tian M,Zhang H,Oriuchi N,et al.Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.Eur J Nucl Med Mol Imaging,2004,31(8):1064-1072.
[14] Zhang H,Tian M,Oriuchi N,et al.11C-choiine PET for the detection of bone and soft tissue tumours in comparison with FDG PET.Nucl Med Commun,2003,24(3):273-279.
[15] Toyohara J,Waki A,Takamatsu S,et al.Basis of FLT as a cell proliferation marker:comparative uptake studies with [3H]thymidine and [3H]arabinothymidine,and cell-analysis in 22 asynchronously growing tumor cell line.Nucl Med Biol,2002,29(3):281-287.
[16] Rasey JS,Grierson JR,Wiens LW,et al.Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.J Nucl Med,2002,43(9):1210-1217.
[17] Chen W,Cloughesy T,Kamdar N,et al.Imaging proliferation in brain tumors with 18F-FLT PET:comparison with 18F-FDG.J Nucl Med,2005,46(6):945-952.
[18] Jacobs AH,Thomas A,Kracht LW,et al.18F-fluoro-L-tKymidine and 11C methylmethionine as markers of increased transport and proliferation in brain tumors.J Nucl Med,2005,46(12):1948-1958.
[19] Pirotte B,Goldman S,Massager N,et al.Combined use of 18F-fluorodeoxyglucose and 11C methionine in 45 positron emission tomography-guided stereotactic brain biopsies.J Neurosurg,2004,101(3):476-483.
[20] Pirotte B,Goldman S,Massager N,et al.Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.J Nucl Med,2004,45(8); 1293-1298.
[21] Grosu AL,Weber WA,Franz M,et al.Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.Int J Radiat Oncol Biol Phys,2005,63(2):511-519.
[22] Ribom D,Engler H,Blomquist E,et al.Potential significance of (11) C-methionine PET as a marker for the radiosensitivity of low-grade gliomas.Eur J Nucl Med Mol Imaging,2002,29(5):632-640.
[23] Kim S,Chung JK,Im SH,et al.11C-methionine PET as a prognostic marker in patients with glioma:comparison with 18F-FDG PET.Eur J Nucl Med Mol Imaging,2005,32(1):52-59.
[24] Van Laere K,Ceyssens S,Van Calenbergh F,et al.Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma:sensitivity,inter-observer variability and prognostic value.Eur J Nucl Med Mol Imaging,2005,32(1):39-51.
[25] Rachinger W,Goetz C,Popperl G,et a l.Positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas.Neurosurgery,2005,57(3):505-511.
[26] Chen W,Cloughesy T,Kamdar N,et al.Imaging proliferation in brain tumors with 18F-FLT PET:comparison with 18F-FDG.J Nucl Med,2005,46(6):945-952.